Modern Healthcare News
 
RSS feed

Pfizer news and information

Information
Baxter to offload vaccine business to Pfizer for $635 million
By Kristen Schorsch, Crain's Chicago Business | July 31, 2014
Baxter International is selling its vaccine business to Pfizer for $635 million as it prepares to split into two companies.
FULL STORY »
 

Information
Pfizer's 2Q profit sinks 79% but tops forecasts
By Associated Press | July 29, 2014
Pfizer's second-quarter earnings plunged 79% from last year, when the world's second-largest drugmaker booked a $10 billion-plus gain from a business spinoff.
FULL STORY »
 

Magazine
Tax reform fears driving Big Pharma mergers
By Beth Kutscher | July 19, 2014 | Print Magazine Print Magazine Subscription Details
The rumblings that corporate tax reform will close favorable loopholes for pharmaceutical and biotechnology companies are getting louder, fueling a rush of high-dollar cross-border deals.
FULL STORY »
 

Information
Pfizer withdraws spurned offer for AstraZeneca
By Associated Press | May 26, 2014
Pfizer said Monday that it does not intend to make a takeover offer for British drugmaker AstraZeneca, pulling the plug for now on what would have been the largest deal in the industry's history.
FULL STORY »
 

Magazine
Drug prices spotlighted in AstraZeneca deal
By Beth Kutscher | May 24, 2014 | Print Magazine Print Magazine Subscription Details
With a May 26 deadline looming, British drug giant AstraZeneca is holding firm in its refusal to accept a $119 billion offer from Pfizer to create the world's largest pharmaceutical company.
FULL STORY »
 


Advertisement | View Media Kit

News
AstraZeneca holding firm against Pfizer's advances
By Beth Kutscher | May 23, 2014 | Basic Web Basic Web Subscription Details
With a May 26 deadline looming, British drug giant AstraZeneca is holding firm in its refusal to accept a $119 billion offer from rival Pfizer to create the world's largest pharmaceutical company. The record-setting offer is just one of a slew of mega-deals this year in the pharmaceutical and...
FULL STORY »
 

Information
AstraZeneca rejects Pfizer's 'final' $116B bid
By USA Today | May 19, 2014
British drug maker AstraZeneca rejected Monday what its New York-based rival Pfizer called over the weekend its "final" takeover offer.
FULL STORY »
 

Magazine
Pfizer faces lawsuits that claim Lipitor caused diabetes
By Joe Carlson | May 17, 2014 | Print Magazine Print Magazine Subscription Details
Several hundred women are suing Pfizer in federal court, alleging the company knew that women taking Lipitor faced an increased risk of developing Type 2 diabetes and that Pfizer's warning label did not clearly describe that risk.
FULL STORY »
 

Information
AstraZeneca rejects sweetened Pfizer takeover bid
By Associated Press | May 02, 2014
Pharmaceutical company AstraZeneca on Friday flatly rejected drug maker Pfizer's sweetened takeover bid — worth $106 billion — just hours after it was levelled, describing it as inadequate.
FULL STORY »
 

Information
AstraZeneca shares soar on Pfizer interest
By Associated Press | April 28, 2014
Shares in Anglo-Swedish drugmaker AstraZeneca jumped 15% on Monday after U.S. pharmaceutical company Pfizer said it offered to buy the company for around $100 billion.
FULL STORY »
 

Search ModernHealthcare.com:


 

Switch to the new Modern Healthcare Daily News app

For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.